Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q1 2024 Earnings Call Transcript

Operator: Good morning, and welcome to Intellia Therapeutics’ First Quarter 2024 Financial Results Conference Call.

Keep Reading →